Skip to Content
Merck
All Photos(1)

Documents

56919

Supelco

Perfluoroperhydrophenanthrene

Selectophore

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C14F24
CAS Number:
Molecular Weight:
624.11
Beilstein:
2514226
MDL number:
UNSPSC Code:
26111700
PubChem Substance ID:
NACRES:
NB.61

grade

for ion-selective electrodes

Quality Level

description

solvent for preparation of membranes

product line

Selectophore

bp

212-218 °C

density

2.03 g/mL at 20 °C

SMILES string

FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(C1(F)F)C(F)(F)C(F)(F)C3(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C23F

InChI

1S/C14F24/c15-1-2(16)4(18,10(29,30)14(37,38)12(33,34)6(2,21)22)8(25,26)7(23,24)3(1,17)9(27,28)13(35,36)11(31,32)5(1,19)20

InChI key

QKENRHXGDUPTEM-UHFFFAOYSA-N

General description

Visit our Sensor Applications portal to learn more.

Application

Perfluoroperhydrophenanthrene finds application as an intraoperative and postoperative surgical adjunct tool, during retinal operations and study.
Solvent for fluorous liquid phase in ion-selective electrodes

Legal Information

Selectophore is a trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

H Wafapoor et al.
International ophthalmology, 22(2), 89-96 (1999-09-03)
To evaluate the utility and efficacy of perfluoroperhydrophenanthrene in the management of retinal detachments secondary to severe proliferative diabetic retinopathy. Forty consecutive patients with proliferative diabetic retinopathy and retinal detachments were entered into the study at nine participating clinical centers.
Ulrike Stolba et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 242(11), 931-936 (2004-07-20)
To evaluate the histological changes in the retina after experimental vitreous substitution with various amounts of perfluorophenanthrene (PFPH). Thirty-two rabbit eyes were mechanically vitrectomized and filled up with 0.8 cc or 0.2 cc highly purified PFPH. The substance remained for
U Stolba et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 237(6), 501-507 (1999-06-24)
We evaluated biomicroscopic and histological effects on the anterior segment in the rabbit eye after temporary aqueous substitution with various amounts (0.2 cc and 0.025 cc) of perfluorodecaline (PFD) and perfluorophenanthrene (PFP). A quantity of 0.2 cc of the two
I U Scott et al.
Ophthalmology, 107(5), 860-865 (2000-05-16)
To compare rates of perfluorocarbon liquid (PFCL) intraocular retention, anatomic and visual acuity outcomes, and complications associated with intraoperative perfluoro-n-octane (Perfluoron) versus perfluoroperhydrophenanthrene (Vitreon) in retinal detachment repair. Retrospective noncomparative consecutive case series. Records of consecutive patients who underwent retinal
A Loewenstein et al.
Ophthalmology, 107(6), 1078-1082 (2000-06-17)
To compare two perfluorocarbon liquids, perfluoroperhydrophenanthrene (Vitreon) and perfluoro-n-octane (PFO), regarding (1) ease of removal at the time of surgery and (2) efficacy and safety. Retrospective, nonrandomized, comparative trial. Two hundred sixty-four patients. All medical records of patients who participated

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service